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0024-3205/© 2014 Elsevier Inc. Open access under CC BYa b s t r a c ta r t i c l e i n f oAvailable online 28 September 2014 The Thirteenth International Conference on Endothelin (ET-13) was held from September 8–11, 2013 in Tokyo,
Japan chaired by Noriaki Emoto, Kobe Pharmaceutical University, Japan, and Takashi Miyauchi, University of
Tsukuba, Japan and held on the Tokyo Campus of Tsukuba University. The International Conferences on
Endothelin were launched in December of 1988 shortly after the discovery of endothelin and organized by Sir
John Vane, laureate of the Nobel Prize in Physiology or Medicine 1982, as the Conference Chair at The William
Harvey Research Institute, London. Since then, the conference has been held every two years alternating between
North America, Europe and Asia. In 2013, the conference was again held in Asia and also marked the 25th
anniversary of the discovery of endothelin at University of Tsukuba. The 25th anniversary of the discovery of
endothelin was celebrated by almost 300 attendees from 25 different countries, the largest number of delegates
in the recent history of the conference. Conference delegates who traveled to Japan were from Argentina,
Australia, Austria, Brazil, Canada, China, Czech Republic, Denmark, France, Germany, Greece, Hong Kong,
Hungary, Indonesia, Italy, Japan, Korean Republic, Netherlands, Sweden, Switzerland, Taiwan, Turkey, United
Kingdom, United States, and from Vietnam. In this article we summarize the conference highlights, its speakers,
and some of the festivities related to the celebration of the 25th anniversary of the discovery of endothelin.
© 2014 Elsevier Inc.Open access under CC BY-NC-ND license.The International Conferences on Endothelin were launched in
December of 1988 shortly after the discovery of endothelin
(Yanagisawa et al., 1988) and organized by Sir John Vane, Ph.D. F.R.S.,
laureate of the Nobel Prize in Physiology or Medicine 1982 (Raju,
1999), as the Conference Chair at The William Harvey Research
Institute, London (Vane et al., 1989). Since then, the conference has
been held every two years alternating between North America, Europe
and Asia (Emoto et al., 2014b-in this issue). In 2013, the conference
was again held in Asia and also marked the 25th anniversary of the dis-
covery of endothelin at University of Tsukuba.
The Thirteenth International Conference on Endothelin (ET-13) was
held from September 8–11, 2013 in Tokyo, Japan (Fig. 1) chaired by
Noriaki Emoto, M.D. Ph.D. (Kobe Pharmaceutical University, Japan)
and Takashi Miyauchi, M.D. Ph.D. (University of Tsukuba, Japan) onarmacy, Kobe Pharmaceutical
artment of Internal Medicine,
-0017, Japan. Tel.: +81 78 382
-NC-ND license.the Tokyo Campus of Tsukuba University (Fig. 2). The 25-year anniver-
sary of the discovery of endothelin was celebrated by almost 300
attendees from 25 different countries, the largest number of delegates
in the recent years of the conference (Fig. 3). The countries from
which scientists and physicians came to Japan included Argentina,
Australia, Austria, Brazil, Canada, China, Czech Republic, Denmark,
France, Germany, Greece, Hong Kong, Hungary, Indonesia, Italy, Japan,
Korean Republic, Netherlands, Sweden, Switzerland, Taiwan, Turkey,
United Kingdom, United States, and Vietnam. At ET-13, a number of
invited and keynote lectures were given by a panel of international
experts from basic, clinical and translational science. These experts
included Jennifer S. Pollock, Ph.D. (Augusta) (Fig. 4), Matthias Barton
M.D. (Zurich), Francesca Spinella Ph.D. (Rome), Pierre-Louis Tharaux,
M.D. Ph.D. (Paris), HiroshiWatanabe, M.D. Ph.D. (Hamamatsu), Toyoaki
Murohara M.D. Ph.D. (Nagoya), David J. Webb, M.D. (Edinburgh), Kenji
Sunagawa, M.D. Ph.D. (Hakata), Anil Gulati, M.D. Ph.D. (Chicago),
Yasushi Kawaguchi, M.D. PhD. (Tokyo), Michelle L. Gumz, Ph.D.
(Gainesville), Hiroki Kurihara M.D. Ph.D. (Tokyo), David Langleben,
M.D. (Montréal), Hiromi Matsubara M.D. Ph.D. (Okayama), Masaru
HatanoM.D. Ph.D. (Tokyo), Yoshihide Asano,M.D. Ph.D. (Tokyo), Ronald
Oudiz, M.D. (Torrance), Ivana Vaněčková, Ph.D. (Prague), Donald E.
Kohan, M.D. Ph.D. (Salt Lake City), Jo De Mey, M.D. (Odense), Theoﬁlos
M. Kolettis, M.D. (Ioannina), Berthold Hocher, M.D. (Potsdam), Ariela
Fig. 1. A view from the Tokyo Dome Hotel on the city of Tokyo (current population: 31.7 million) where the Thirteenth International Conference on Endothelin was held in September
2013. On the right the Tokyo Skytree (634 m/2080 ft) can be seen, the second-highest free standing structure in the world over 350 m (1148 ft).
71N. Emoto, M. Yanagisawa / Life Sciences 118 (2014) 70–76Benigni, Ph.D. (Bergamo), Masafumi Kitakaze M.D. Ph.D. (Osaka),
and Carmine Cardillo, M.D. (Rome). New data on clinical studies with
endothelin receptor antagonists was presented by representatives ofFig. 2. The entrance of the Tsukuba University, Tokyo Campus, the venue of the Thirteenth In
endothelin was identiﬁed in 1987 and published in the Spring of 1988 (Yanagisawa et al. 1988the pharmaceutical industry, including Dennis L. Andress, M.D.
(Chicago), Martine Clozel, M.D. (Allschwil), and Hunter C. Gillies, M.D.
(Foster City).ternational Conference on Endothelin. At Tsukuba University, the molecular structure of
).
Fig. 3. Faculty and conference attendees of the Thirteenth International Conference on Endothelin gathered on the Kyouiku-no-mori Park (教育の森公園) near Tokyo Campus of the
University of Tsukuba.
Photo courtesy of Suzete Sandin.
72 N. Emoto, M. Yanagisawa / Life Sciences 118 (2014) 70–76In the Honorary Chair Session, Paul M. Vanhoutte, M.D. Ph.D. (Hong
Kong) presented a lecture entitled “End o' the Line Revisited” in which
he gave an overview of endothelial regulation of vascular tone during
the course of 25 years of endothelin research (De Mey and Vanhoutte,
2014-in this issue). The Special Guest Lecture was delivered by JunFig. 4. Jennifer Pollock, Ph.D, of the Georgia Regents University, Augusta, GA, speaking to th
foreground: session chairs Pedro d'Orléans Juste, Ph.D. (Sherbrooke) and Soichi Miwa, M.D. Ph
Photo courtesy of Suzete Sandin.Yamashita, M.D. Ph.D. (Kyoto), a close collaborator of Shinya Yamanaka,
M.D. Ph.D.who received the 2012Nobel Prize in Physiology orMedicine
for his discoveries in stem cell research (Colman, 2013). Dr. Yamashita's
lecture was entitled “Multiple and Integrative Approaches to Cardiovas-
cular Diseases with Stem Cell Technology.” With what has become ae conference audience in the lecture hall of Tsukuba University, Tokyo Campus. In the
.D. (Hokkaido).
Fig. 5. Atsushi Tanaka, M.D., Keio University, Tokyo during his lecture on cardiomyocytes
that were derived from hypertrophic cardiomyopathy-induced pluripotent stem cells.
Photo courtesy of Suzete Sandin.
73N. Emoto, M. Yanagisawa / Life Sciences 118 (2014) 70–76tradition at the endothelin conferences, a lecture by Masashi
Yanagisawa,M.D. Ph.D. (Tsukuba) concluded the conference summariz-
ing the highlights of ET-13, and again addressing the next generation of
endothelin researchers with a personal message (Barton and Pollock,
2012).
During the conference, a number of young investigators presented
data from their research work at the scientiﬁc sessions as well as at
the poster sessions, all of which were chaired by international experts
from basic science and clinical medicine (Emoto et al., 2014c-in thisFig. 6. The Conference Chairs, Noriaki Emoto, M.D. Ph.D. and Takashi Miyauchi, M.
Photo courtesy of Suzete Sandin.issue) (Figs. 5, 6). All sessions took place at Tokyo Campus of Tsukuba
University (Figs. 2, 4) and the academic venue was ideal for young re-
searchers to present, share and discuss their data with senior investiga-
tors (Emoto et al., 2014c-in this issue). The Conference Chairs honored
two young scientists with the ET-13 Best Presentation Awards (co-
sponsored with Elsevier Publishers) for the best presentations of a talk
or poster, respectively. The prize for best oral presentation went to
Johannes P. Backs, M.D. (Germany), and David J. Durgan Ph.D (USA) re-
ceived the prize for best poster presentation (Emoto et al., 2014c-in this
issue). In addition to new basic research, numerous areas of interest for
the potential clinical application of endothelin antagonists or
endothelin-converting enzyme inhibitors were introduced, including
not only renal and cardiovascular diseases but also cancer, inﬂamma-
tion, pain, diabetes and related diseases; studies also addressed diseases
such as osteoarthritis, retinal disease and blindness, Alzheimer's dis-
ease, and many more (Abdelsaid et al., 2014-in this issue; Caprara
et al., 2014-in this issue; Cianfrocca et al., 2014-in this issue; Finzi
et al., 2014-in this issue; Freeman et al., 2014-in this issue; Fukumoto
et al., 2014-in this issue; Shimojo et al., 2014-in this issue; Tanaka
et al., 2014-in this issue).
At the conference dinner held at the Tokyo Dome Hotel on
September 10, 2013 (Fig. 7), scientists from 25 different countries
celebrated the anniversary of the discovery of endothelin (Emoto
et al., 2014c-in this issue). As a special highlight, nine young investiga-
tors aged 25 or less in 2013 who represent the next generation of
endothelin researchers, were invited to prepare prior to the conference
to present a haiku (俳句), a traditional form of Japanese poetry
consisting of no more than three short verses and 27 on, or Japanese
phonetic units). The young investigators presented their endothelin-
haikus at the conference dinner, both in their native language and inD. Ph.D. (center) with the recipients of the ET-13 Young Investigator awards.
Fig. 7. Conference attendees celebrating the 25th anniversary of the discovery of endothelin at the ET-13 conference dinner, held at the Tokyo Dome Hotel on September 10, 2013.
Photo courtesy of Suzete Sandin.
74 N. Emoto, M. Yanagisawa / Life Sciences 118 (2014) 70–76an English translation (Emoto et al., 2014c-in this issue). These haikus
have been published in another article in this issue (Emoto et al.,
2014c-in this issue). On the last day of the ET-13, the Conference Chairs
announced Professor Katsutoshi Goto, Ph.D. (Tsukuba) as the recipient
of the Second Tomoh Masaki Award (Emoto et al., 2014a-in this issue).
The Thirteenth International Conference on Endothelin would not
have been possible without the tremendous help and support of a
large number individuals and organizations, including members of the
ET-13 Local Organizing Committee, the ET-13 International Scientiﬁc
Advisory Committee, the Endothelin International Advisory Board
(ET-IAB), and our conference sponsors. We express our appreciation
to Takashi Miyauchi, M.D. Ph.D. as ET-13 Co-Chair, and Tomoh Masaki,
M.D. Ph.D, Katsutoshi Goto, PhD., and Paul M. Vanhoutte, M.D. Ph.D.,
as ET-13 Honorary Conference Chairs (Emoto, 2014-in this issue). We
thank the ET-13 Secretary Generals, Satoshi Sakai, M.D. Ph.D., and
Nicolas Vignon-Zellweger, Ph.D, for their invaluable help in organizing
this conference. We are particularly grateful for all abstract reviewers
and the chairs of the scientiﬁc sessions who were essential in ensuring
a high scientiﬁc quality of the conference program.
As Conference Chairs, we particularly thank our ofﬁcial institutional
sponsors, the American Physiology Society, the British Pharmacological
Society, the Japanese Circulation Society, International Society of
Nephrology, University of Tsukuba, Japan Society for the Promotion of
Science (JSPS), the Uehara Foundation, and the Japanese Pharmacologi-
cal Society. We also thank all industrial sponsors for providing unre-
stricted educational grants to support the conference. This ﬁnancial
support allowed us to give a record number of sixty-nine ET-13 Young
Investigator Awards and grants to early career young scientists inrecognition of the excellence of their research to be presented at the
ET-13 conference (Fig. 8).
We are grateful to all members of ET-13 Conference Secretariat for
an outstanding job with the organization of the meeting and proving
incredible ﬂexibility in the most difﬁcult situations. We also thank
Suzete Sandin (Sherbrooke) who again served as the ofﬁcial conference
photographer and Angus Hubbard and Steve Sobal (London) for ﬁlming
of ET-13. We thank the board of the University of Tsukuba, Tokyo
Campus, who made it possible for us to have the meeting at the same
University that was the birthplace of endothelin.
We thank all the people at Elsevier and Life Sciences, particularly
Christine Kisthard and Ruthie Hewitt, who helped us with their profes-
sionalism, their publishing expertise, their help with the Open Access™
publication of the ET-13 conference abstracts (Emoto, 2013) and for
their patience and tremendous support during the preparation of the
Endothelin XIII proceedings (Emoto, 2014-in this issue). We also
thank Anne Marie Pordon, the publisher of Life Sciences, for supporting
and sponsoring the idea of the “ET-13 Best Presentation Awards”. As
with the previous meeting (von Brandenstein et al., 2012), the ET Best
Presentation Award comes with an invitation for the awardee to
contribute a review article on a subject of research to be published in
Life Sciences (Lehmann et al., 2014-in this issue). Finally, we have to
thank all speakers, presenters, session chairs, abstract reviewers, manu-
script reviewers, and supporters for their contribution.
The Fourteenth International Conference on Endothelin (ET-14)will
be held in Savannah, GA, USA from September 2–5, 2015 and chaired by
Adviye Ergul, M.D. Ph.D., Anil Gulati, M.D. Ph.D., and David M. Pollock,
Ph.D. (endothelins.com, 2015). We are convinced that at ET-14 we
Young Investigator Award 
Shamima Akter Japan Matthias R. Meyer USA 
Oliver Baretella Hong Kong Kazuhiko Nakayama Japan 
Vicente Bermudez Argentina Meghana M. Pandit USA 
Joseph Cacioppo USA Julia Straube Germany 
Fernando P. Filgueira Brazil Kazuko Tajiri Japan 
Susi Heiden Japan Hung Van Tran Japan 
Martin Houde Canada Nicolas Vignon-Zellweger Japan 
Kelly A. Hyndman USA Melanie von Brandenstein Germany 
Subrina Jesmin Japan Amanda K. Welch USA 
Dimitrios Kapsokalyvas The Netherlands Chunyi Wen Hong Kong
Olivia Lenoir France Bambang Widyantoro Indonesia 
Mary G. Leonard USA Raphael Wurm Austria 
Heike Loeser Germany Tsunehisa Yamamoto Japan 
Takeshi Machino Japan Toru Yoshikawa Japan 
Yuri C. Martins USA 
Travel Grant Award 
Dyah Wulan Anggrahini Indonesia Gregory Star Canada 
Nur Arfian Indonesia Sarah L. Trinder UK 
Jongki Cho USA Jale Yuzugulen UK 
Matthijs G. Compeer The Netherlands Shinya Fukumoto Japan 
Louisane Desbiens Canada Majedul Islam Japan 
Daniel Erces Hungary Akemi Kakino Japan 
Alessandro Finzi Italy Most. Tanzila Khatun Japan 
Brandi D. Freeman USA Kento Kitada Japan 
Samer-ul Haque UK Hiroshi Kumagai Japan 
J. Brett Heimlich USA Toshinori Minamishima Japan 
Fabian Heunisch Germany Hironori Muraoka Japan 
Danielle Kamato Australia Mami Nishikawa Japan 
Thomas M. Leurgans Denmark Yoshie Nogami Japan 
Varut Lohsiriwat Thailand Takeshi Otsuki Japan 
Rheure Lopes Brazil Kaori Sato Japan 
Andras T. Meszaros Hungary Aiko Sonobe Japan 
Rebecca C. Moorhouse UK Koichiro Tanahashi Japan 
Xeni Provatopoulou Greece Saori Yamamoto Japan 
Joshua S. Speed USA Kanako Yokoi Japan 
Fig. 8. Names and countries of origin of the recipients of the ET-13 Young Investigator Awards (YIAs and travel grants) who presented their research at the ET-13 meeting in Tokyo.
75N. Emoto, M. Yanagisawa / Life Sciences 118 (2014) 70–76will seemany new exciting presentations about themost recent in basic
and clinical endothelin research. We sincerely wish the ET-14
Conference Chairs-Elect energy with the preparation of the meeting
and much success. We are looking forward to seeing exciting new
endothelin science to be presented at ET-14 in September 2015.
Appendix A. Supplementary data
Supplementary video to this article “Impressions from the Thir-
teenth International Conference on Endothelin, Tokyo, Japan, Septem-
ber 8-11, 2013” can be found online at http://dx.doi.org/10.1016/j.lfs.
2014.09.020.
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